Andrew M Green sold $911k of AORT
SVP, Regulatory and Quality at ARTIVION, INC.. 44,001 shares at an average of $20.70, traded Jun 11, 2026, filed Jun 15, 2026.
Score components
- +15RoleOfficer
- +24Trade size$911k at market
- +20Share of holdings soldSold 59% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-043059, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | MOption exercise Common Stock10b5-1 | +14,001 | $18.44 | $258k | 74,260 | Jun 15, 2026 |
| Jun 11, 2026 | SOpen-market sale Common Stock10b5-1 | -14,001 | $20.71 | $290k | 60,259 | Jun 15, 2026 |
| Jun 11, 2026 | MOption exercise Common Stock10b5-1 | +30,000 | $11.03 | $331k | 90,259 | Jun 15, 2026 |
| Jun 11, 2026 | SOpen-market sale Common Stock10b5-1 | -30,000 | $20.69 | $621k | 60,259 | Jun 15, 2026 |
| Jun 11, 2026 | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -14,001 | $0.00 | $0 | 0 | Jun 15, 2026 |
| Jun 11, 2026 | MOption exercise Stock Options (Right to buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 0 | Jun 15, 2026 |
Related signals
Other insiders at ARTIVION, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | AORTsell ARTIVION, INC. | Andrew M Green SVP, Regulatory and Quality | $287k 11,480 shares | -22% | |
| 40Moderate | ARTIVION, INC. | Andrew M Green SVP, Regulatory and Quality | $216k 8,003 shares | -13% | |
| 65Notable | ARTIVION, INC. | James P Mackin President & CEO | $2.0M 70,000 shares | -7% | |
| 37Weak | ARTIVION, INC. | Lance A Berry EVP, COO, CFO & Treasurer | $20k 715 shares | -0% | |
| 30Weak | ARTIVION, INC. | Andrew M Green SVP, Regulatory and Quality | $18k 616 shares | -1% | |
| 35Weak | ARTIVION, INC. | Jean F Holloway SVP, General Counsel | $28k 977 shares | -1% | |
| 60Notable | ARTIVION, INC. | James P Mackin President & CEO | $676k 17,887 shares | -2% | |
| 50Moderate | ARTIVION, INC. | Lance A Berry EVP, COO, CFO & Treasurer | $239k 6,316 shares | -3% | |
| 41Moderate | ARTIVION, INC. | John E Davis Chief Commercial Officer | $173k 4,573 shares | -2% | |
| 39Weak | ARTIVION, INC. | Marshall S. Stanton SVP, Clinical & MD Affair | $81k 2,149 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.